JPMorgan initiates Wyndham Hotels stock with overweight rating

JPMorgan initiated coverage on Wyndham Hotels (WH) with an Overweight rating and a $101 price target, identifying it as a compelling relative value in the lodging sector. The bank highlighted WH's significant valuation discount, trading at 10 times 2026 estimated EV/EBITDA, which is 4-7 times below larger peers like Hilton and Marriott despite similar projected 6-7% EBITDA growth for fiscal year 2025, suggesting an excessive valuation gap. This assessment is supported by Wyndham's recent Q1 2025 results, which reported a 9% increase in adjusted EBITDA and consistent global system growth, reinforcing its strategic positioning and long-term potential.

Analysis

JPMorgan has initiated coverage on Wyndham Hotels (WH) with an Overweight rating and a $101 price target, identifying a significant valuation anomaly in the lodging sector. The core of the thesis rests on Wyndham's valuation at 10 times 2026 estimated EV/EBITDA, which represents a substantial discount of 4-7 times to larger peers like Hilton and Marriott, and a 2 times discount to its own historical average. JPMorgan argues this valuation gap is excessive, particularly as Wyndham's projected fiscal year 2025 EBITDA growth of 6-7% is in line with these competitors. While acknowledging Wyndham's slower estimated net unit growth of 4%, the analysis suggests the market is overly penalizing the stock. This bullish view is supported by recent fundamentals from Wyndham's first quarter, which showed a 9% increase in adjusted EBITDA and 4% global system growth, despite a minor revenue miss. The company's financial profile is further bolstered by impressive gross profit margins of 67.44% and a consistent, growing dividend yielding 2.07%. Although the company projects a cautious full-year global RevPAR range of -2% to +1%, its strategic focus on technology, international expansion, and a long-term net room growth target of 3-5% underpin the positive outlook.

Key Decisions for Investors

• Investors should consider the relative value proposition highlighted by JPMorgan, as Wyndham's stock appears significantly undervalued compared to peers Hilton and Marriott, despite posting similar EBITDA growth projections.
• It is critical to monitor Wyndham's ability to achieve its guided 3-5% long-term net room growth, as closing the unit growth gap with competitors could serve as a primary catalyst for a valuation re-rating.
• While the long-term thesis is compelling, investors must weigh the cautious near-term RevPAR guidance against strong fundamental metrics like 9% adjusted EBITDA growth and high gross margins to assess the immediate risk-reward balance.
• For those seeking a total return strategy, Wyndham's healthy 2.07% dividend yield, coupled with a history of consistent growth, provides an income component that complements the potential for capital appreciation from a multiple expansion.